Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chemin

Showing results (431-440 of 452) with videos related to

Pageof 46
Sort By:
The Science of the Total Environment|December 6, 2024
Retraction notice to "Effects of nanocapsules of poly-ε-caprolactone containing artemisinin on zebrafish early-life stages and adults" [Sci. Total Environ. 756 (2021) 143851]Ives Charlie-Silva, Natália Martins Feitosa, Hirla Costa Silva Fukushima, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
The Science of the Total Environment|December 1, 2020
Effects of nanocapsules of poly-ε-caprolactone containing artemisinin on zebrafish early-life stages and adultsIves Charlie-Silva, Natália Martins Feitosa, Hirla Costa Silva Fukushima, et al.
Eclinicalmedicine|June 15, 2026
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in FranceJean-Yves Blay, Vincent Thevenet, Emmanuel Oger, et al.
The Journal of Clinical Investigation|November 10, 2015
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesInka Albrecht, Cecilia Wick, Åsa Hallgren, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
Brain : a Journal of Neurology|June 8, 2018
De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel geneJean Chemin, Karine Siquier-Pernet, Michaël Nicouleau, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2024
Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experienceAnne-Laure Genevois, Matthieu Carton, Myriam Jean-Denis, et al.
Pageof 46

Showing results (431-440 of 452) with videos related to

Sort By:
Pageof 46
The Science of the Total Environment|December 6, 2024
Retraction notice to "Effects of nanocapsules of poly-ε-caprolactone containing artemisinin on zebrafish early-life stages and adults" [Sci. Total Environ. 756 (2021) 143851]Ives Charlie-Silva, Natália Martins Feitosa, Hirla Costa Silva Fukushima, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
The Science of the Total Environment|December 1, 2020
Effects of nanocapsules of poly-ε-caprolactone containing artemisinin on zebrafish early-life stages and adultsIves Charlie-Silva, Natália Martins Feitosa, Hirla Costa Silva Fukushima, et al.
Eclinicalmedicine|June 15, 2026
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in FranceJean-Yves Blay, Vincent Thevenet, Emmanuel Oger, et al.
The Journal of Clinical Investigation|November 10, 2015
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesInka Albrecht, Cecilia Wick, Åsa Hallgren, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
Brain : a Journal of Neurology|June 8, 2018
De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel geneJean Chemin, Karine Siquier-Pernet, Michaël Nicouleau, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2024
Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experienceAnne-Laure Genevois, Matthieu Carton, Myriam Jean-Denis, et al.
Pageof 46